Revenue
36.4 thousand USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 36400 USD Source
Fundies. English
ADVANCED MEDICAL ISOTOPE Corp
EDGARAnnual consolidated revenue for 2025: about USD 68.38K, using the latest reported figures. The previous period, 2024, was about USD 28K.
Latest quarter
Operating margin
-1,798.16%
2026 Q2 · %
Operating cash flow
-740 thousand USD
2026 Q2 · USD
Free cash flow
-834 thousand USD
2026 Q2 · USD
- Cash and cash equivalents
- 3.27 million USD Source
Exact value
3265100 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 494 million shares Source
Exact value
494214360 shares
Reported share-count change
8.90% · 40.4 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
99.1 thousand USD
2025-07-01 – 2026-06-30
Net income
-3.6 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-2.17 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -1518189 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -1059708 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -2057743 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -1518189 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -429861 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -1169441 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -429861 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-12.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 8 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- Capital expenditure: 1 of 11 periods available· newest 2025-12-31
- Total assets: 8 of 11 periods available· newest 2025-12-31
- Total liabilities: 8 of 11 periods available· newest 2025-12-31
- Current assets: 8 of 11 periods available· newest 2025-12-31
- Current liabilities: 8 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 7 of 11 periods available· newest 2024-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 8 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+144.3%Prior period
USD 27,995
–
Current period
USD 68,379
–
Exact inputs and evidence
68379 − 27995 = 40384 USD
27995 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source68379 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 155,569Prior period
−USD 2.91 million
–
Current period
−USD 3.07 million
–
Exact inputs and evidence
-3066017 − -2910448 = -155569 USD
-2910448 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-3066017 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 373,704Prior period
−USD 1.68 million
–
Current period
−USD 2.06 million
–
Exact inputs and evidence
-2057743 − -1684039 = -373704 USD
-1684039 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-2057743 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 68,379 100% of revenue
- Cost of revenue USD 128,134 187% of revenue
- Operating expenses USD 3.11 million 4,541% of revenue
- Operating income −USD 3.17 million −4,629% of revenue
- Tax, interest and other Derived −USD 99,030 −145% of revenue
- Net income −USD 3.07 million −4,484% of revenue
Cash
- Operating cash flow −USD 2.06 million −3,009% of revenue
- Capital expenditure USD 103,185 151% of revenue
- Free cash flow Derived −USD 2.16 million −3,160% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Operating loss: operating costs were 64,651% of revenue.
- 2019 Operating loss: operating costs were 14,100% of revenue.
- 2020 Operating loss: operating costs were 9,707% of revenue.
- 2021 Operating loss: operating costs were 16,905% of revenue.
- 2022 Operating loss: operating costs were 6,998% of revenue.
- 2023 Operating loss: operating costs were 14,424% of revenue.
- 2024 Operating loss: operating costs were 9,403% of revenue.
- 2025 Operating loss: operating costs were 4,729% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | 4054 | 2620968 Derived | -2616914 | 3801813 Derived | -6418727 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 9500 | 1339479 Derived | -1329979 | 280118 Derived | -1610097 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 7000 | 679521 Derived | -672521 | 284471 Derived | -956992 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 14887 | 2516685 Derived | -2501798 | 25968 Derived | -2527766 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 36499 | 2554248 Derived | -2517749 | -47588 Derived | -2470161 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 19500 | 2812646 Derived | -2793146 | 101607 Derived | -2894753 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 27995 | 2632379 Derived | -2604384 | 306064 Derived | -2910448 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 68379 | 3233426 Derived | -3165047 | -99030 Derived | -3066017 | -2160928 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 68.4K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Revenue | 4054 |
|
| 2019 | Revenue | 9500 |
|
| 2020 | Revenue | 7000 |
|
| 2021 | Revenue | 14887 |
|
| 2022 | Revenue | 36499 |
|
| 2023 | Revenue | 19500 |
|
| 2024 | Revenue | 27995 |
|
| 2025 | Revenue | 68379 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
144.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Year over year | No prior comparable period |
|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | -26.3% |
|
| 2021 | Year over year | 112.7% |
|
| 2022 | Year over year | 145.2% |
|
| 2023 | Year over year | -46.6% |
|
| 2024 | Year over year | 43.6% |
|
| 2025 | Year over year | 144.3% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -4,628.7% 2025
Net margin -4,483.9% 2025
Free cash flow margin -3,160.2% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Operating margin | -64,551.4% |
|
| 2019 | Operating margin | -13,999.8% |
|
| 2020 | Operating margin | -9,607.4% |
|
| 2021 | Operating margin | -16,805.3% |
|
| 2022 | Operating margin | -6,898.1% |
|
| 2023 | Operating margin | -14,323.8% |
|
| 2024 | Operating margin | -9,303% |
|
| 2025 | Operating margin | -4,628.7% |
|
| 2017 | Net margin | -158,330.7% |
|
| 2019 | Net margin | -16,948.4% |
|
| 2020 | Net margin | -13,671.3% |
|
| 2021 | Net margin | -16,979.7% |
|
| 2022 | Net margin | -6,767.7% |
|
| 2023 | Net margin | -14,844.9% |
|
| 2024 | Net margin | -10,396.3% |
|
| 2025 | Net margin | -4,483.9% |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | -3,160.2% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -2.1M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Operating cash flow | -1288075 |
|
| 2019 | Operating cash flow | -837113 |
|
| 2020 | Operating cash flow | -875807 |
|
| 2021 | Operating cash flow | -963819 |
|
| 2022 | Operating cash flow | -1120058 |
|
| 2023 | Operating cash flow | -1293023 |
|
| 2024 | Operating cash flow | -1684039 |
|
| 2025 | Operating cash flow | -2057743 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -2.2M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | -2160928 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
11.1% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Liabilities / assets | 27,254.7% |
|
| 2019 | Liabilities / assets | 3,472.7% |
|
| 2020 | Liabilities / assets | 96.6% |
|
| 2021 | Liabilities / assets | 10.2% |
|
| 2022 | Liabilities / assets | 4.7% |
|
| 2023 | Liabilities / assets | 15.2% |
|
| 2024 | Liabilities / assets | 3.9% |
|
| 2025 | Liabilities / assets | 11.1% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
14× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Current assets / current liabilities | 0× |
|
| 2019 | Current assets / current liabilities | 0.03× |
|
| 2020 | Current assets / current liabilities | 1.04× |
|
| 2021 | Current assets / current liabilities | 9.79× |
|
| 2022 | Current assets / current liabilities | 21.33× |
|
| 2023 | Current assets / current liabilities | 6.57× |
|
| 2024 | Current assets / current liabilities | 25.91× |
|
| 2025 | Current assets / current liabilities | 14× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | −USD 9.85 million Exact valueExact value: -9854895 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.93 million Exact valueExact value: -1926713 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −USD 6.42 million Exact valueExact value: -6418727 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.29 million Exact valueExact value: -1288075 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −USD 7.7 million Exact valueExact value: -7702845 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 700,454 Exact valueExact value: -700454 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 1.61 million Exact valueExact value: -1610097 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 837,113 Exact valueExact value: -837113 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 956,992 Exact valueExact value: -956992 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 875,807 Exact valueExact value: -875807 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 2.53 million Exact valueExact value: -2527766 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 963,819 Exact valueExact value: -963819 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 2.47 million Exact valueExact value: -2470161 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.12 million Exact valueExact value: -1120058 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 2.89 million Exact valueExact value: -2894753 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.29 million Exact valueExact value: -1293023 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 2.91 million Exact valueExact value: -2910448 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.68 million Exact valueExact value: -1684039 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 3.07 million Exact valueExact value: -3066017 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.06 million Exact valueExact value: -2057743 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 103,185 Exact valueExact value: 103185 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.16 million Calculation and evidence-2057743 − 103185 USD Exact free cash flow: -2160928 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
87 filings · 3,261 latest values · 3,261 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001449349, 1449349, ADMD, RDGL, edgar:1449349
Also known as ADVANCED MEDICAL ISOTOPE Corp, VIVOS INC, VIVOS INC, VIVOS INC.